THE COMPARATIVE STUDY OF MEDICAL DEVICE REGULATION OF INDIA AND FOREIGN COUNTRIES: A REVIEW

J. Patel, P. Kapupara
{"title":"THE COMPARATIVE STUDY OF MEDICAL DEVICE REGULATION OF INDIA AND FOREIGN COUNTRIES: A REVIEW","authors":"J. Patel, P. Kapupara","doi":"10.17628/ECB.2021.10.167-170","DOIUrl":null,"url":null,"abstract":"Medical devices are used vastly used in the healthcare pharmaceutical industry throughout the world. It has become the integral part of modern medical industry. The dependency on the medical device has increased handsomely in treatment of any diseases. This dependency has led to quality issues in medical care. By using medical devices for the treatment of diseases has improved the patient's health, but sometimes they also complicate the condition of the patients, as the body does not accept them and consider them as a foreign body. Therefore, for the manufacturing of medical devices, safety and quality are given prime importance in its regulation. The regulations are different in different countries at present. The medical device regulation of the US, European region, China, Japan, is more stringent and advanced. In India, the Government has come out with medical device regulation in 2017 for manufacturing companies. These are regularly updated based on the western world. But still, Indian regulation is not stringent as some of the medical devices are still notified as drugs to cap price regulation. This paper studies the current scenario in India with other foreign countries regarding the regulations of medical devices. It concludes that we cannot accept any medical device as it is accepted elsewhere. The acceptance must be from the Indian Government; trials must be conducted in India and must be notified and made public for any damages, recalled action. This will help our local manufacturers compete other manufacturers worldwide, create more jobs and economic growth based on the Make in India concept.","PeriodicalId":11880,"journal":{"name":"European Chemical Bulletin","volume":"10 1","pages":"167-170"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Chemical Bulletin","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17628/ECB.2021.10.167-170","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Chemistry","Score":null,"Total":0}
引用次数: 0

Abstract

Medical devices are used vastly used in the healthcare pharmaceutical industry throughout the world. It has become the integral part of modern medical industry. The dependency on the medical device has increased handsomely in treatment of any diseases. This dependency has led to quality issues in medical care. By using medical devices for the treatment of diseases has improved the patient's health, but sometimes they also complicate the condition of the patients, as the body does not accept them and consider them as a foreign body. Therefore, for the manufacturing of medical devices, safety and quality are given prime importance in its regulation. The regulations are different in different countries at present. The medical device regulation of the US, European region, China, Japan, is more stringent and advanced. In India, the Government has come out with medical device regulation in 2017 for manufacturing companies. These are regularly updated based on the western world. But still, Indian regulation is not stringent as some of the medical devices are still notified as drugs to cap price regulation. This paper studies the current scenario in India with other foreign countries regarding the regulations of medical devices. It concludes that we cannot accept any medical device as it is accepted elsewhere. The acceptance must be from the Indian Government; trials must be conducted in India and must be notified and made public for any damages, recalled action. This will help our local manufacturers compete other manufacturers worldwide, create more jobs and economic growth based on the Make in India concept.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
印度与国外医疗器械监管比较研究综述
医疗器械在世界各地的医疗保健制药行业中被广泛使用。它已成为现代医疗工业不可分割的组成部分。在治疗任何疾病时,对医疗设备的依赖都大大增加了。这种依赖性导致了医疗保健的质量问题。使用医疗设备治疗疾病改善了患者的健康,但有时也会使患者的病情复杂化,因为身体不接受这些设备,并将其视为异物。因此,对于医疗器械的生产,安全和质量在其监管中至关重要。目前,不同国家的规定不同。美国、欧洲地区、中国、日本的医疗器械监管更加严格和先进。在印度,政府已于2017年出台了针对制造企业的医疗器械监管。这些都是根据西方世界定期更新的。但尽管如此,印度的监管并不严格,因为一些医疗器械仍被通知为药品,以限制价格监管。本文研究了印度与其他国家在医疗器械监管方面的现状。它的结论是,我们不能像其他地方接受的那样接受任何医疗器械。接受必须来自印度政府;审判必须在印度进行,并且必须通知并公开任何损害、召回行动。这将有助于我们当地的制造商与全球其他制造商竞争,创造更多的就业机会,并在印度制造理念的基础上实现经济增长。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
European Chemical Bulletin
European Chemical Bulletin Chemistry-Chemistry (all)
自引率
0.00%
发文量
0
审稿时长
6 weeks
期刊最新文献
GREEN SYNTHESIS OF COPPER NANOPARTICLES FROM AN EXTRACT OF AZADIRACHTA INDICA LEAVES AND CHARACTERIZATION IMPACT OF COMPREHENSIVE NUTRITIONAL COUNSELING ON CLINICAL OUTCOME AND QUALITY OF LIFE IN PATIENTS WITH DIABETIC NEPHROPATHY THE ASSESSMENT OF KNOWLEDGE AND ATTITUDE TOWARDS OBESITY AND BARIATRIC SURGERY AMONG NURSES WORKING IN TERTIARY CARE HOSPITALS LAHORE NURSE’S KNOWLEDGE, ATTITUDE AND PRACTICE TOWARD THE ADMINISTRATION OF OXYGEN THERAPY TO THE CRITICALLY ILL PATIENTS EFFECTS OF DIFFERENT FIBER DIETS ON THE GROWTH PERFORMANCE, BLOOD PROFILES, IMMUNE RESPONSE, MEAT QUALITY AND ECONOMY IN GROWING AND FINISHING PIGS
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1